RNA-DIRECTED PROTEASE SYSTEMS AND USES THEREOF

Provided herein are compositions, systems, and methods comprising effector proteins, and uses thereof. These effector proteins may be characterized as CRISPR-associated (Cas) proteins. Various compositions, systems, and methods of the present disclosure may leverage the activities of these effector...

Full description

Saved in:
Bibliographic Details
Main Authors CHAIKIND, Brian R, ABBOTT, Timothy Robert
Format Patent
LanguageEnglish
French
Published 11.07.2024
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Provided herein are compositions, systems, and methods comprising effector proteins, and uses thereof. These effector proteins may be characterized as CRISPR-associated (Cas) proteins. Various compositions, systems, and methods of the present disclosure may leverage the activities of these effector proteins for such applications as detecting genetic mutations and treating various diseases and disorders. L'invention concerne des compositions, des systèmes et des méthodes comprenant des protéines effectrices et leurs utilisations. Ces protéines effectrices peuvent être caractérisées en tant que protéines associées à CRISPR (Cas). Divers compositions, systèmes et méthodes de la présente invention peuvent tirer profit des activités de ces protéines effectrices pour de telles applications en tant que détection de mutations génétiques et traitement de divers maladies et troubles.
Bibliography:Application Number: WO2024US10545